Colleen Tupper - 10 Feb 2026 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: COLL
Reported as of: 10 Feb 2026
Net transaction value: -$1,801,745
SEC form: 4
Accepted by SEC: 12 Feb 2026, 16:30:11 UTC
Prior SEC filing: 07 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Colleen Tupper

Key filing fact

Colleen Tupper filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 12 Feb 2026.

Key facts

This page summarizes Colleen Tupper's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 Feb 2026, 16:30.

Change

Previous filing in this sequence was filed on 07 Nov 2025.
Current net transaction value: -$1,801,745.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001862082 Primary reporting owner

Tupper Colleen

Relationship: EVP & Chief Financial Officer
Address: C/O COLLEGIUM PHARMACEUTICAL, INC., 100 TECHNOLOGY CENTER DRIVE, STOUGHTON
Signature: /s/ Colleen Tupper
Signature date: 12 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

COLL transaction

Common Stock

Award

Transaction value: $0
Shares: +26,421
Change %: +21%
Price: $0.000000
Shares after: 153,088
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F1

COLL transaction

Common Stock

Award

Transaction value: $0
Shares: +32,734
Change %: +21%
Price: $0.000000
Shares after: 185,822
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F2

COLL transaction

Common Stock

Tax liability

Transaction value: $554,502
Shares: -11,861
Change %: -6.4%
Price: $46.75
Shares after: 173,961
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F3

COLL transaction

Common Stock

Tax liability

Transaction value: $1,247,243
Shares: -26,679
Change %: -15%
Price: $46.75
Shares after: 147,282
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Footnote F2

Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,734 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.

Footnote F3

Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.

Footnote F4

Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.